Biogen (Brazil) Today

BIIB34 Stock  BRL 150.16  2.24  1.47%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Biogen is trading at 150.16 as of the 23rd of December 2024, a 1.47 percent decrease since the beginning of the trading day. The stock's open price was 152.4. Biogen has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of November 2024 and ending today, the 23rd of December 2024. Click here to learn more.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 867.48 M outstanding shares. More on Biogen Inc

Moving against Biogen Stock

  0.9P2LT34 Palantir TechnologiesPairCorr
  0.88AXPB34 American ExpressPairCorr
  0.86WALM34 WalmartPairCorr
  0.85BMYB34 Bristol Myers SquibbPairCorr
  0.85MRFG3 Marfrig Global FoodsPairCorr
  0.84VISA34 Visa IncPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Biogen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biogen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biogen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
PresidentRobin Kramer
Business ConcentrationDrug Manufacturers - Major, Healthcare (View all Sectors)
Biogen Inc (BIIB34) is traded on Sao Paulo Exchange in Brazil and employs 9,610 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 218.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biogen's market, we take the total number of its shares issued and multiply it by Biogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biogen Inc operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 867.48 M outstanding shares. Biogen Inc has accumulated about 3.91 B in cash with 3.64 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.16.
Check Biogen Probability Of Bankruptcy

Biogen Inc Risk Profiles

Although Biogen's alpha and beta are two of the key measurements used to evaluate Biogen's performance over the market, the standard measures of volatility play an important role as well.

Biogen Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biogen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Additional Information and Resources on Investing in Biogen Stock

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.